Pacira Biosciences Inc (PCRX)

Operating Expenses

$143.97M

Quarterly · Period ending: · USD

PCRX logo

PCRX Operating Expenses

Latest reported$143.97M
PCRX Quarterly Operating Expenses ($7.16M → $143.97M)
High-resolution chart · PNG

PCRX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pacira Biosciences Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
143,968,000
136,338,000
153,383,000
138,876,000
131,734,000
132,627,000
122,663,000
269,236,000
105,521,000
106,489,000
100,384,000
106,455,000
81,383,000
114,412,000
119,932,000
95,499,000
87,549,000
104,524,000
115,976,000
61,638,000
65,499,000
68,241,000
76,895,000
69,871,000
60,347,000
58,858,000
88,807,000
72,350,000
68,723,000
62,902,000
58,821,000
59,076,000
56,488,000
58,569,000
49,206,000
52,419,000
58,408,000
58,752,000
51,742,000
46,068,000
53,031,000
47,450,000
50,706,000
41,203,000
38,401,000
37,395,000
34,905,000
32,642,000
30,053,000
27,793,000
25,008,000
21,282,000
18,937,000
18,841,000
16,607,000
14,905,000
12,285,000
12,446,000
9,330,000
9,332,000
9,052,000
7,318,000
5,763,000
7,410,000
5,834,000
5,653,000
8,616,000
7,161,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.